Fine Balance

While the newly announced £311 million investment in the UK's 100,000 Genomes Project may enable insights into health and disease, an editorial in the Observer notes that patient data must be protected for the project to be successful.

"Leaks will lead to a loss of faith among patients whose support for the project is crucial and will have to be prevented at all costs," it adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.